Details for Patent: 12,128,132
Which drugs does patent 12,128,132 protect, and when does it expire?
Patent 12,128,132 protects UZEDY and is included in one NDA.
This patent has twenty-two patent family members in eighteen countries.
Summary for Patent: 12,128,132
| Title: | Drug delivery formulations |
| Abstract: | The present invention is directed to methods of treating psychiatric diseases and disorders comprising administering to a subject in need thereof an injectable formulation comprising risperidone, triblock and diblock copolymers wherein the concentration of the risperidone is 250-400 mg/mL and injection volume is 1 mL or less. |
| Inventor(s): | Anthony RECH, Christophe Roberge, Eran HARARY |
| Assignee: | MedinCell SA , Teva Pharmaceutical Industries Ltd |
| Application Number: | US18/391,243 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 12,128,132
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | UZEDY | risperidone | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 213586-001 | Apr 28, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF BIPOLAR DISORDER | ⤷ Start Trial | |||
| Teva | UZEDY | risperidone | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 213586-001 | Apr 28, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Start Trial | |||
| Teva | UZEDY | risperidone | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 213586-002 | Apr 28, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF BIPOLAR DISORDER | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,128,132
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020346455 | ⤷ Start Trial | |||
| Australia | 2025242078 | ⤷ Start Trial | |||
| Brazil | 112022004535 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
